Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 2, 2025
Diagnostic value of MRI for posttreatment surveillance of early-stage (I-II) glottic larynx cancerLucas Mose, Emre Korkmaz, Miranda Visini, et al.
Cancers|December 23, 2023
Five Fractions versus Seven Fractions SBRT for Intermediate- and High-Risk Prostate Cancer: A Propensity Score Matched Pair AnalysisChristina Schröder, Lucas Mose, Etienne Mathier, et al.
Frontiers in Oncology|October 11, 2024
Treatment and related morbidity of nasal cavity and paranasal sinus cancersNils Smaadahl, Sara-Lynn Hool, Philipp Reinhardt, et al.
Frontiers in Oncology|June 14, 2021
Image-Guided Robotic Radiosurgery for the Treatment of Same Site Spinal Metastasis RecurrencesFelix Ehret, Lucas Mose, Markus Kufeld, et al.
Cancers|February 15, 2022
Intracranial Hemorrhage in Patients with Anticoagulant Therapy Undergoing Stereotactic Radiosurgery for Brain Metastases: A Bi-Institutional AnalysisFelix Ehret, David Kaul, Lucas Mose, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|January 14, 2025
Prognostic significance of the mEPE score in intermediate-risk prostate cancer patients undergoing ultrahypofractionated robotic SBRTLucas Mose, Laura Isabel Loebelenz, Alexander Althaus, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 23, 2025
Radiosurgery for pediatric central nervous system lesions - initial report and insights from a multicenter registryFelix Ehret, Lucas Mose, Luisa Allwohn, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 27, 2025
Evaluation of compartmentalized automatic segmentation for definition of the GTV in glioblastoma radiotherapyRobert Poel, Lucas Mose, Philipp Reinhardt, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 28, 2025
Predicting the impact of target volume contouring variations on the organ at risk dose: results of a qualitative surveyJonas Willmann, Amith Kamath, Robert Poel, et al.
Prostate Cancer and Prostatic Diseases|April 8, 2024
Role of enzalutamide in primary and recurrent non-metastatic hormone sensitive prostate cancer: a systematic review of prospective clinical trialsMohamed Shelan, Vérane Achard, Felix Appiagyei, et al.
Pageof 2